openPR Logo
Press release

Global Genotyping Market Size Worth USD 38.7 Billion By 2030 | CAGR 12.5%: Infinium Global Research

Global Genotyping Market Size Worth USD 38.7 Billion By 2030 |

Infinium Global Research announces the release of an extensive report delving into the Genotyping Market, providing a profound analysis of segments, sub-segments, and the significant impact of drivers, restraints, and macro indicators on the global and regional Genotyping Market. The report offers a comprehensive depiction of trends, forecasts, and monetary valuations within the global Genotyping Market landscape.

To Know More Request a Sample of this Report: https://www.infiniumglobalresearch.com/market-reports/sample-request/1233

Market Overview and Projections

The Genotyping Market, valued at USD 13.3 billion in 2022, is anticipated to surge to USD 38.7 billion by 2030, exhibiting a robust Compound Annual Growth Rate (CAGR) of 12.5% during the forecast period from 2023 to 2030.

Unlocking the Genetic Code: Advancements in Genotyping

Genotyping involves the analysis of an individual's genetic material, such as DNA, to identify specific genetic variations or markers. Utilizing techniques like PCR, DNA sequencing, and microarray analysis, it assists in determining an individual's genetic makeup, offering insights into disease predisposition, medication response, ancestry, and trait associations. The applications span across medicine, genetics research, agriculture, forensics, and population genetics, enabling breakthroughs in disease understanding, targeted therapies, and agricultural advancements.

Drivers and Contributions to Market Growth

The rising incidence of genetic diseases like cancer, diabetes, and tuberculosis significantly propels the genotyping market forward. Genotyping plays a pivotal role in comprehending the genetic factors associated with these diseases, leading to enhanced disease management, personalized treatments, and precise interventions. Moreover, its crucial role in the pharmaceutical industry, fostering the need for more effective treatments and personalized medicine, continues to drive market growth, prompting increased research and development in the sector.

Challenges and Technological Advancements

While stringent regulations and unfavorable reimbursement practices pose limitations, technological advancements in genotyping, especially through DNA microarray technology, promise significant market growth. The deployment of advanced genotyping technologies enhances resolution and accuracy, revolutionizing the field.

Regional Dynamics and Market Segments

North America is poised to dominate the Genotyping Market, supported by advanced healthcare infrastructure, robust R&D activities, and increased adoption of personalized medicine. Conversely, the Asia Pacific region emerges as the fastest-growing market, driven by a burgeoning population and a rising prevalence of genetic diseases, amplifying the need for genotyping technologies.

Detailed Segments Covered in the Report

The report segments the global Genotyping Market based on product (instruments, reagents & kits, bioinformatics, software, and services), technology (PCR, microarrays, sequencing, etc.), application (pharmacogenomics, diagnostics, personalized medicine, etc.), and end-use (pharmaceutical companies, diagnostics labs, academic institutes, etc.).

Profiles of Key Market Players

The report encompasses detailed profiles of industry leaders such as Illumina, Inc., Thermo Fisher Scientific Inc., QIAGEN, F. Hoffmann-La Roche Ltd, Fluidigm (now Standard BioTools), Danaher, Agilent Technologies, Inc., Eurofins Scientific, GE HealthCare, and BGI Group, shedding light on their strategies and market positioning.

Enquire Here Get Customization & Check the Discount for the Report @ https://www.infiniumglobalresearch.com/market-reports/customization/1233

Table of Content

Chapter 1. Preface

1.1. Report Description

1.2. Research Methods

1.3. Research Approaches

Chapter 2. Executive Summary

2.1. Genotyping Market Highlights

2.2. Genotyping Market Projection

2.3. Genotyping Market Regional Highlights

Chapter 3. Global Genotyping Market Overview

3.1. Introduction

3.2. Market Dynamics

3.2.1. Drivers

3.2.2. Restraints

3.2.3. Opportunities

3.3. Porter`s Five Forces Analysis

3.4. IGR-Growth Matrix Analysis

3.4.1. IGR-Growth Matrix Analysis by Product

3.4.2. IGR-Growth Matrix Analysis by Technology

3.4.3. IGR-Growth Matrix Analysis by Application

3.4.4. IGR-Growth Matrix Analysis by End-use

3.4.5. IGR-Growth Matrix Analysis by Region

3.5. Value Chain Analysis of Genotyping Market

Chapter 4. Genotyping Market Macro Indicator Analysis

Chapter 5. Company Profiles and Competitive Landscape

5.1. Competitive Landscape in the Global Genotyping Market

5.2. Companies Profiles

5.2.1. Illumina, Inc.

5.2.2. Thermo Fisher Scientific Inc.

5.2.3. QIAGEN

5.2.4. F. Hoffmann-La Roche Ltd

5.2.5. Fluidigm (is now Standard BioTools)

5.2.6. Danaher

5.2.7. Agilent Technologies, Inc.

5.2.8. Eurofins Scientific

5.2.9. GE HealthCare

5.2.10. BGI Group

Chapter 6. Global Genotyping Market by Product

6.1. Instruments

6.2. Reagents & Kits

6.3. Bioinformatics

6.4. Software and Services

Chapter 7. Global Genotyping Market by Technology

7.1. PCR

7.2. Capillary Electrophoresis

7.3. Microarrays

7.4. MALDI-TOF

7.5. Sequencing

7.6. Mass Spectrometry

7.7. Others

Chapter 8. Global Genotyping Market by Application

8.1. Pharmacogenomics

8.2. Diagnostics

8.3. Personalized Medicine

8.4. Agricultural Biotechnology

8.5. Animal Genetic

8.6. Others

Chapter 9. Global Genotyping Market by End-use

9.1. Pharmaceutical and Biopharmaceutical Companies

9.2. Diagnostics and Research Laboratories

9.3. Academic Institutes

9.4. Others

Chapter 10. Global Genotyping Market by Region 2023-2030

10.1. North America

10.1.1. North America Genotyping Market by Product

10.1.2. North America Genotyping Market by Technology

10.1.3. North America Genotyping Market by Application

10.1.4. North America Genotyping Market by End-use

10.1.5. North America Genotyping Market by Country

10.1.5.1. The U.S. Genotyping Market

10.1.5.1.1. The U.S. Genotyping Market by Product

10.1.5.1.2. The U.S. Genotyping Market by Technology

10.1.5.1.3. The U.S. Genotyping Market by Application

10.1.5.1.4. The U.S. Genotyping Market by End-use

10.1.5.2. Canada Genotyping Market

10.1.5.2.1. Canada Genotyping Market by Product

10.1.5.2.2. Canada Genotyping Market by Technology

10.1.5.2.3. Canada Genotyping Market by Application

10.1.5.2.4. Canada Genotyping Market by End-use

10.1.5.3. Mexico Genotyping Market

10.1.5.3.1. Mexico Genotyping Market by Product

10.1.5.3.2. Mexico Genotyping Market by Technology

10.1.5.3.3. Mexico Genotyping Market by Application

10.1.5.3.4. Mexico Genotyping Market by End-use

10.2. Europe

10.2.1. Europe Genotyping Market by Product

10.2.2. Europe Genotyping Market by Technology

10.2.3. Europe Genotyping Market by Application

10.2.4. Europe Genotyping Market by End-use

10.2.5. Europe Genotyping Market by Country

10.2.5.1. Germany Genotyping Market

10.2.5.1.1. Germany Genotyping Market by Product

10.2.5.1.2. Germany Genotyping Market by Technology

10.2.5.1.3. Germany Genotyping Market by Application

10.2.5.1.4. Germany Genotyping Market by End-use

10.2.5.2. United Kingdom Genotyping Market

10.2.5.2.1. United Kingdom Genotyping Market by Product

10.2.5.2.2. United Kingdom Genotyping Market by Technology

10.2.5.2.3. United Kingdom Genotyping Market by Application

10.2.5.2.4. United Kingdom Genotyping Market by End-use

10.2.5.3. France Genotyping Market

10.2.5.3.1. France Genotyping Market by Product

10.2.5.3.2. France Genotyping Market by Technology

10.2.5.3.3. France Genotyping Market by Application

10.2.5.3.4. France Genotyping Market by End-use

10.2.5.4. Italy Genotyping Market

10.2.5.4.1. Italy Genotyping Market by Product

10.2.5.4.2. Italy Genotyping Market by Technology

10.2.5.4.3. Italy Genotyping Market by Application

10.2.5.4.4. Italy Genotyping Market by End-use

10.2.5.5. Rest of Europe Genotyping Market

10.2.5.5.1. Rest of Europe Genotyping Market by Product

10.2.5.5.2. Rest of Europe Genotyping Market by Technology

10.2.5.5.3. Rest of Europe Genotyping Market by Application

10.2.5.5.4. Rest of Europe Genotyping Market by End-use

10.3. Asia Pacific

10.3.1. Asia Pacific Genotyping Market by Product

10.3.2. Asia Pacific Genotyping Market by Technology

10.3.3. Asia Pacific Genotyping Market by Application

10.3.4. Asia Pacific Genotyping Market by End-use

10.3.5. Asia Pacific Genotyping Market by Country

10.3.5.1. China Genotyping Market

10.3.5.1.1. China Genotyping Market by Product

10.3.5.1.2. China Genotyping Market by Technology

10.3.5.1.3. China Genotyping Market by Application

10.3.5.1.4. China Genotyping Market by End-use

10.3.5.2. Japan Genotyping Market

10.3.5.2.1. Japan Genotyping Market by Product

10.3.5.2.2. Japan Genotyping Market by Technology

10.3.5.2.3. Japan Genotyping Market by Application

10.3.5.2.4. Japan Genotyping Market by End-use

10.3.5.3. India Genotyping Market

10.3.5.3.1. India Genotyping Market by Product

10.3.5.3.2. India Genotyping Market by Technology

10.3.5.3.3. India Genotyping Market by Application

10.3.5.3.4. India Genotyping Market by End-use

10.3.5.4. South Korea Genotyping Market

10.3.5.4.1. South Korea Genotyping Market by Product

10.3.5.4.2. South Korea Genotyping Market by Technology

10.3.5.4.3. South Korea Genotyping Market by Application

10.3.5.4.4. South Korea Genotyping Market by End-use

10.3.5.5. Australia Genotyping Market

10.3.5.5.1. Australia Genotyping Market by Product

10.3.5.5.2. Australia Genotyping Market by Technology

10.3.5.5.3. Australia Genotyping Market by Application

10.3.5.5.4. Australia Genotyping Market by End-use

10.3.5.6. Rest of Asia-Pacific Genotyping Market

10.3.5.6.1. Rest of Asia-Pacific Genotyping Market by Product

10.3.5.6.2. Rest of Asia-Pacific Genotyping Market by Technology

10.3.5.6.3. Rest of Asia-Pacific Genotyping Market by Application

10.3.5.6.4. Rest of Asia-Pacific Genotyping Market by End-use

10.4. RoW

10.4.1. RoW Genotyping Market by Product

10.4.2. RoW Genotyping Market by Technology

10.4.3. RoW Genotyping Market by Application

10.4.4. RoW Genotyping Market by End-use

10.4.5. RoW Genotyping Market by Sub-region

10.4.5.1. Latin America Genotyping Market

10.4.5.1.1. Latin America Genotyping Market by Product

10.4.5.1.2. Latin America Genotyping Market by Technology

10.4.5.1.3. Latin America Genotyping Market by Application

10.4.5.1.4. Latin America Genotyping Market by End-use

10.4.5.2. Middle East Genotyping Market

10.4.5.2.1. Middle East Genotyping Market by Product

10.4.5.2.2. Middle East Genotyping Market by Technology

10.4.5.2.3. Middle East Genotyping Market by Application

10.4.5.2.4. Middle East Genotyping Market by End-use

10.4.5.3. Africa Genotyping Market

10.4.5.3.1. Africa Genotyping Market by Product

10.4.5.3.2. Africa Genotyping Market by Technology

10.4.5.3.3. Africa Genotyping Market by Application

10.4.5.3.4. Africa Genotyping Market by End-use

More Insights on this report, Speak to Our Analyst: https://www.infiniumglobalresearch.com/market-reports/enquiry/1233

Reasons to Buy this Report:

=> Comprehensive analysis of global as well as regional markets of Genotyping.

=> Complete coverage of all the product types and application segments to analyze the trends, developments, and forecast of market size up to 2030.

=> Comprehensive analysis of the companies operating in this market. The company profile includes an analysis of the product portfolio, revenue, SWOT analysis, and the latest developments of the company.

=> Infinium Global Research- Growth Matrix presents an analysis of the product segments and geographies that market players should focus on to invest, consolidate, expand, and/or diversify.

2nd Floor, Ganadish Empire, Rahatani Chowk, Pimple Saudagar, Pimpri-Chinchwad, Maharashtra 411027

About Infinium Global Research:

Infinium Global Research is a business consulting and market research firm; a group of experts that caters to fulfilling business and market research needs of leading companies in various industry verticals and business segments. The company also serves government bodies, institutes, and non-profit/non-government organizations to meet their knowledge and information needs.

Through our information services and solutions, we assist our clients to improve their performance and assess the market conditions to achieve their organizational goals. Our team of experts and analysts are engaged in continuously monitoring and assessing the market conditions to provide knowledge support to our clients. To help our clients and to stay updated with the advances and inventions in technology, business processes, regulations, and the environment, Infinium often conducts regular meets with industry experts and opinion leaders. Our key opinion leaders are involved in monitoring and assessing the progress in the business environment, so as to offer the best opinion to our clients.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Genotyping Market Size Worth USD 38.7 Billion By 2030 | CAGR 12.5%: Infinium Global Research here

News-ID: 3302402 • Views:

More Releases from Infinium Global Research LLP

Global Sterilization Services Market Size Worth USD 12.55 Billion By 2030 | CAGR 7.24%: Infinium Global Research
Global Sterilization Services Market Size Worth USD 12.55 Billion By 2030 | CAGR …
Infinium Global Research, a leading provider of market intelligence, has recently launched an in-depth report on the Global Sterilization Services Market, offering comprehensive analysis and detailed insights into its segments and market trends. The comprehensive study explores the impact of various factors such as drivers, restraints, and macro indicators on both the global and regional sterilization services market, providing crucial forecasts and dollar value projections. To Know More Request a Sample of
Global Proprotein Convertase Subtilisin/Kexin Type 9 Market is Projected to Surpass USD 5.09 Billion By the End of 2030 with a Growing CAGR of 9.56% | Infinium Global Research
Global Proprotein Convertase Subtilisin/Kexin Type 9 Market is Projected to Surp …
Infinium Global Research introduces a detailed analysis of the global and regional Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) market, providing an extensive study of its segments, trends, forecasts, and dollar values in their latest report. This comprehensive study empowers stakeholders in the pharmaceutical and healthcare sectors with invaluable insights into this burgeoning market. To Know More Request a Sample of this Report: https://www.infiniumglobalresearch.com/market-reports/sample-request/420 Market Insight: The global Proprotein Convertase Subtilisin/Kexin Type 9 market,
Global Neuromodulation Market is Anticipated to Reach USD 7.27 Billion and Growing at a CAGR of 9.59% During Forecast Period 2023 - 2030 | IGR
Global Neuromodulation Market is Anticipated to Reach USD 7.27 Billion and Growi …
Infinium Global Research, a pioneering market intelligence firm, introduces a comprehensive report delving into the Global Neuromodulation Market, providing extensive analysis and in-depth exploration of its segments, market trends, and projections. To Know More Request a Sample of this Report: https://www.infiniumglobalresearch.com/market-reports/sample-request/93 Market Insight: The global neuromodulation market, valued at USD 3.51 Billion in 2022, is poised to ascend to USD 7.27 Billion by 2030, exhibiting a noteworthy CAGR of 9.59% during the forecast
Global Botulinum Toxin Market Growing at a CAGR of 9.12% to Reach USD 20.09 Billion By 2030 | Infinium Global Research
Global Botulinum Toxin Market Growing at a CAGR of 9.12% to Reach USD 20.09 Bill …
Infinium Global Research, a leading market intelligence firm, has released an extensive report delving into the dynamics and trends shaping the Global Botulinum Toxin Market. This comprehensive analysis spans both the global landscape and regional perspectives, providing invaluable insights into the market's trajectory, influencing factors, and growth projections. To Know More Request a Sample of this Report: https://www.infiniumglobalresearch.com/market-reports/sample-request/89 Market Insight: The global botulinum toxin market, valued at USD 10.02 billion in 2022, is

All 5 Releases


More Releases for Genotyping

Genotyping Market Development, Industry, Gradual Growth, With Forecast 2021 -202 …
Market Overview The study includes overall insights into the market and the diverse views of various industry experts. Existing market investigation and future exploration are described to provide better insight into your business. The study further describes the size and estimation of the genotyping market during the forecast period. It also presents an entire qualitative and quantitative information and the impact analysis of any affecting factors on future market growth aspects.
Asia Pacific is the fastest growing Single Nucleotide Polymorphism (SNP) Genotyp …
Single Nucleotide Polymorphism (SNP) is usually a mutation found at a specific locus or a single base pair mutation containing two alleles. SNPs aid in understanding the correlations among genotype and behavior indicated by all living organisms. SNP genotyping is the measurement of genetic variations that commonly occur in individuals. Unlike conventional time consuming, expensive and labor extensive detection technology, SNP technology is highly efficient, relatively inexpensive and automated. Get
Genotyping Market Industry Trends 2018
The global genotyping market is expected to reach $17.0 Billion in 2020 from $6.2 Billion in 2015, at a CAGR of 22.3% during the forecast period of 2015 to 2020. Market growth will be attributed to the availability of a range of products for wide applications, decreasing prices of DNA sequencing, increasing incidence of and awareness on genetic diseases and personalized medicine, increasing demand for pharmacogenomics in drug discovery and
Genotyping Analysis Services Market: Long-Term Growth 2024 Update
Genotyping is increasingly used to study genetic makeup and variation in the genotypes of various living organisms, such as humans, plants, and animal, including microorganism. Genotyping tests are extensively used in various development processes of drug discovery and in providing personalized therapies to treat a host of genetic diseases. There is an increasing demand for various genotyping analysis services across developed and developing regions. This is expected to lower the cost
Genotyping Analysis Services Market share will expand till 2024
Global Genotyping Analysis Services Market: Overview Genotyping is increasingly used to study genetic makeup and variation in the genotypes of various living organisms, such as humans, plants, and animal, including microorganism. Genotyping tests are extensively used in various development processes of drug discovery and in providing personalized therapies to treat a host of genetic diseases. Request Sample Copy of the Report@ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2441    There is an increasing demand for various genotyping analysis services across developed
Global SNP Genotyping Market Size, Status and Forecast 2022
This report studies the global SNP Genotyping market, analyzes and researches the SNP Genotyping development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like Illumina Affymetrix Applied Biosystems Agilent Technologies Beckman Coulter Roche Qiagen Luminex Corporation Enzo Life Sciences Bio-rad Sequenom GenScript GE Healthcare GenScript Douglas Scientific BGI Beijing Sunbiotech HuaGene Biotech Generay Biotech Benegene Shanghai Biochi GENESKY HD Biosciences Download Sample Report Copy From Here: http://globalqyresearch.com/download-sample/284996 Market segment by Regions/Countries, this report covers United States EU Japan China India Southeast Asia Market segment by Application, SNP